IBL HealthCare (KAR:IBLHL) EBITDA Margin %: 0.00% (As of . 20)


What is IBL HealthCare EBITDA Margin %?

IBL HealthCare KAR:IBLHL +4.30% EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. IBL HealthCare's EBITDA for the three months ended in . 20 was ₨0.00 Mil. IBL HealthCare's Revenue for the three months ended in . 20 was ₨0.00 Mil. Therefore, IBL HealthCare's EBITDA margin for the quarter that ended in . 20 was 0.00%.

IBL HealthCare  (KAR:IBLHL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

IBL HealthCare EBITDA Margin % Related Terms

IBL HealthCare EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for IBL HealthCare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IBL HealthCare EBITDA Margin % Chart

IBL HealthCare Annual Data
Trend
EBITDA Margin %

IBL HealthCare Quarterly Data
EBITDA Margin %

KAR:IBLHL vs SNYR, FZMD: EBITDA Margin % Comparison

For the Medical Distribution subindustry, IBL HealthCare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IBL HealthCare EBITDA Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IBL HealthCare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where IBL HealthCare's EBITDA Margin % falls into.


IBL HealthCare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

IBL HealthCare's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

IBL HealthCare's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
IBL HealthCare (KAR:IBLHL) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IBL HealthCare and its competitors.
Is IBL HealthCare's EBITDA Margin % too high?
IBL HealthCare's current EBITDA Margin % is 0.00%.
How does IBL HealthCare's EBITDA Margin % compare to SNYR and FZMD?
IBL HealthCare's EBITDA Margin % of 0.00% can be compared against companies in the Medical Distribution industry. The industry median EBITDA Margin % is 4.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IBL HealthCare and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IBL HealthCare's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IBL HealthCare stock overvalued right now?
IBL HealthCare (KAR:IBLHL) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For IBL HealthCare (KAR:IBLHL), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IBL HealthCare Business Description

Address Tipu Sultan Road, Off. Shahra-e-Faisal, One IBL Centre, 2nd Floor Plot No. 1, Block 7 and 8 Dehli Mercantile Muslim, Cooperative Housing Society, Karachi, SD, PAK
IBL HealthCare Ltd is engaged in the marketing, selling, and distribution of healthcare products. Its product portfolio includes nutritional products, plasma protein components, and hospital disposables.